Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val J Lowe

Showing results (231-240 of 538) with videos related to

Pageof 54
Sort By:
Parkinsonism & Related Disorders|October 12, 2020
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal studyZeynep Idil Seckin, Joseph R Duffy, Edythe A Strand, et al.
Journal of Neurology|February 25, 2022
Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical casesNick Corriveau-Lecavalier, Mary M Machulda, Hugo Botha, et al.
Brain Communications|May 3, 2021
White matter abnormalities are key components of cerebrovascular disease impacting cognitive declinePrashanthi Vemuri, Jonathan Graff-Radford, Timothy G Lesnick, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older AdultsVijay K Ramanan, Scott A Przybelski, Jonathan Graff-Radford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2026
Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of AgingMingzhao Hu, David S Knopman, Terry Therneau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 2, 2024
Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathologyDaniel J Figdore, Heather J Wiste, Joshua A Bornhorst, et al.
Neurology|May 11, 2016
Multimorbidity and neuroimaging biomarkers among cognitively normal personsMaria Vassilaki, Jeremiah A Aakre, Michelle M Mielke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's diseaseJennifer L Whitwell, Peter Martin, Jonathan Graff-Radford, et al.
Brain : a Journal of Neurology|April 3, 2009
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's diseaseClifford R Jack, Val J Lowe, Stephen D Weigand, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 16, 2013
Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasiaJennifer L Whitwell, Val J Lowe, Joseph R Duffy, et al.
Pageof 54

Showing results (231-240 of 538) with videos related to

Sort By:
Pageof 54
Parkinsonism & Related Disorders|October 12, 2020
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal studyZeynep Idil Seckin, Joseph R Duffy, Edythe A Strand, et al.
Journal of Neurology|February 25, 2022
Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical casesNick Corriveau-Lecavalier, Mary M Machulda, Hugo Botha, et al.
Brain Communications|May 3, 2021
White matter abnormalities are key components of cerebrovascular disease impacting cognitive declinePrashanthi Vemuri, Jonathan Graff-Radford, Timothy G Lesnick, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older AdultsVijay K Ramanan, Scott A Przybelski, Jonathan Graff-Radford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2026
Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of AgingMingzhao Hu, David S Knopman, Terry Therneau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 2, 2024
Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathologyDaniel J Figdore, Heather J Wiste, Joshua A Bornhorst, et al.
Neurology|May 11, 2016
Multimorbidity and neuroimaging biomarkers among cognitively normal personsMaria Vassilaki, Jeremiah A Aakre, Michelle M Mielke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's diseaseJennifer L Whitwell, Peter Martin, Jonathan Graff-Radford, et al.
Brain : a Journal of Neurology|April 3, 2009
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's diseaseClifford R Jack, Val J Lowe, Stephen D Weigand, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 16, 2013
Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasiaJennifer L Whitwell, Val J Lowe, Joseph R Duffy, et al.
Pageof 54